ID | 114396 |
著者 |
森本, 佳奈
Tokushima University
|
キーワード | GH-secreting macroadenoma
somatostatin analogue
remarkable shrinkage
|
資料タイプ |
学術雑誌論文
|
抄録 | Acromegaly is caused by excessive growth hormone secretion, usually from pituitary adenomas. Somoatostatin analogues are widely used as primary or adjunctive therapy in the management of acromegaly. In this report, we present a case with remarkable shrinkage of a tumor after relatively short-term octreotide long-acting release (LAR) administration. During the 30-month follow-up after starting octreotide LAR, there was no recurrence of acromegaly with remarkable shrinkage of the tumor on pituitary magnetic resonance imaging. A literature review of the predictors for tumor shrinkage after the administration of somatostatin analogues in patients with acromegaly is also discussed in relation to this case.
|
掲載誌名 |
Internal Medicine
|
ISSN | 13497235
|
出版者 | The Japanese Society of Internal Medicine
|
巻 | 56
|
号 | 18
|
開始ページ | 2455
|
終了ページ | 2461
|
発行日 | 2017-09-15
|
権利情報 | The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
|
EDB ID | |
出版社版DOI | |
出版社版URL | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
出版社版
|
部局 |
病院
医学系
先端酵素学研究所
|